Patients with large tumors, high lymph node metastasis stages, lymphovascular invasion, ER-negative status, PR-negative status, and not receiving radiotherapy were more likely to experience relapse and metastasis. Here, ESR1 is linked to metastatic malignant neoplasm in the lymph nodes.